Hendrx Corp. HDRX Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Hendrx Corp. HDRX Company Overview 

Stock Message Board http://investorshangout.com/search?q=HDRX&...mp;yt1=Go!

Hendrx Corp. HDRX Current Price and Quotes
Last Price 0.004
Previous Close 0.004 Open N/A
Daily Range N/A - N/A 52wk Range 0.01 - 0.0001
Volume 0 Dividend N/A
Average Vol (3m) 29,413 Yield N/A
Hendrx Corp. HDRX
Company Information

748 North Vine Street
Suite #409
Los Angeles, CA 90038

Phone: 818-279-1394

Hendrx Corp. HDRX
Hendrx Corp. HDRX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Sep 30, 2008 10-Q
CIK 0001082696
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 6770 - Blank Checks
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

George Solymar CEO
Company Directors

Not Available
Company Notes

Formerly=StarSoft, Inc. until 3-05
Note=3-31-04 company is in the development stage
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Hendrx Corp. HDRX
HDRX Security Details

Share Structure

Market Value1 $148,952 a/o Sep 13, 2013
Shares Outstanding 37,238,067 a/o Nov 07, 2006
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 375 a/o Apr 14, 2008
Security Notes

Capital Change=shs increased by 15 for 1 split. Ex-date=12/15/2004. Rec date=12/15/2004. Pay date=12/15/2004.
Short Selling Data

Short Interest 0 (-100%)
Jan 15, 2010
Significant Failures to Deliver  No
Transfer Agent(s)



Hendrx Corp. HDRX Recent News

Hendrx Corp. HDRX Financials
HDRX


HDRX Hendrx Corp. Research DD Guide

HDRX Hendrx Corp. Stock Message Board http://investorshangout.com/search?q=HDRX&...mp;yt0=Go!
HDRX Hendrx Corp. Stock Quote http://www.otcmarkets.com/stock/HDRX/quote
HDRX Hendrx Corp. Stock Chart http://www.otcmarkets.com/stock/HDRX/chart
HDRX Hendrx Corp. Company Info http://www.otcmarkets.com/stock/HDRX/company-info
HDRX Hendrx Corp. Recent News http://www.otcmarkets.com/stock/HDRX/news
HDRX Hendrx Corp. Financials http://www.otcmarkets.com/stock/HDRX/financials
HDRX Hendrx Corp. Filings and Disclosure http://www.otcmarkets.com/stock/HDRX/filings
HDRX Hendrx Corp. Short Sales http://www.otcmarkets.com/stock/HDRX/short-sales
HDRX Hendrx Corp. Insider Disclosure http://www.otcmarkets.com/stock/HDRX/insider-transactions
HDRX Hendrx Corp. Research Reports http://www.otcmarkets.com/stock/HDRX/research
HDRX Hendrx Corp. Summary http://finance.yahoo.com/q?s=HDRX
HDRX Hendrx Corp. Historical Prices http://finance.yahoo.com/q/hp?s=HDRX+Historical+Prices
HDRX Hendrx Corp. Interactive Chart http://finance.yahoo.com/echarts?s=HDRX
HDRX Hendrx Corp. Basic Chart http://finance.yahoo.com/q/bc?s=HDRX+Basic+Chart
HDRX Hendrx Corp. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HDRX+Basic+Tech.+Analysis
HDRX Hendrx Corp. Headlines http://finance.yahoo.com/q/h?s=HDRX+Headlines
HDRX Hendrx Corp. Press Releases http://finance.yahoo.com/q/p?s=HDRX+Press+Releases
HDRX Hendrx Corp. Company Profile http://finance.yahoo.com/q/pr?s=HDRX+Profile
HDRX Hendrx Corp. Key Statistics http://finance.yahoo.com/q/ks?s=HDRX+Key+Statistics
HDRX Hendrx Corp. Industry http://finance.yahoo.com/q/in?s=HDRX+Industry
HDRX Hendrx Corp. Major Holders http://finance.yahoo.com/q/mh?s=HDRX+Major+Holders
HDRX Hendrx Corp. Insider Transactions http://finance.yahoo.com/q/it?s=HDRX+Insider+Transactions
HDRX Hendrx Corp. Insider Roster http://finance.yahoo.com/q/ir?s=HDRX+Insider+Roster
HDRX Hendrx Corp. Income Statement http://finance.yahoo.com/q/is?s=HDRX
HDRX Hendrx Corp. Balance Sheet http://finance.yahoo.com/q/bs?s=HDRX
HDRX Hendrx Corp. Cash Flow http://finance.yahoo.com/q/cf?s=HDRX+Cash+Flow&annual
HDRX Hendrx Corp. Nasdaq http://www.nasdaq.com/symbol/HDRX
HDRX Hendrx Corp. Market Watch http://www.marketwatch.com/investing/stock/HDRX
HDRX Hendrx Corp. Bloomberg http://www.bloomberg.com/quote/HDRX:US
HDRX Hendrx Corp. Morningstar http://quotes.morningstar.com/stock/s?t=HDRX
HDRX Hendrx Corp. Bussinessweek http://investing.businessweek.com/research/st...icker=HDRX
HDRX Hendrx Corp. Barchart http://www.barchart.com/quotes/stocks/HDRX
HDRX Hendrx Corp. OTC Short Report http://otcshortreport.com/index.php?index=HDRX
HDRX Hendrx Corp. Investopedia http://www.investopedia.com/markets/stocks/HDRX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading